Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Type of Treatment
1.3.2 Market Segmentation by Type of Scar
1.3.3 Market Segmentation by End User
1.3.4 Analysis Period
1.3.5 Market Data Reporting Unit
1.3.5.1 Value
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By industry participant
2.2.1.2 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Type of Treatment
4.1.1.1 Topical scar treatment
4.1.1.1.1 Cream
4.1.1.1.2 Oil
4.1.1.1.3 Gel
4.1.1.1.4 Gel sheet
4.1.1.1.5 Others
4.1.1.2 Surface scar treatment
4.1.1.2.1 Dermabrasion
4.1.1.2.2 Chemical peeling
4.1.1.2.3 Cryosurgery
4.1.1.3 Laser scar treatment
4.1.1.3.1 CO2 laser
4.1.1.3.2 Er: YAG laser
4.1.1.3.3 Pulsed-dye laser
4.1.1.3.4 Others
4.1.1.4 Injectable scar treatment
4.1.1.4.1 Tissue/dermal filler injection
4.1.1.4.2 Steroid injection
4.1.2 By Type of Scar
4.1.2.1 Post-surgical scar
4.1.2.2 Acne scar
4.1.2.3 Keloid and hypertrophic scar
4.1.2.4 Contracture scar
4.1.2.5 Stretch mark scar
4.1.3 By End User
4.1.3.1 Home-use
4.1.3.2 Hospitals
4.1.3.3 Dermatology clinics
4.1.3.4 Others
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Increasing demand for silicon-based scar treatment products
4.2.1.2 Growing online retailing of scar treatment products
4.2.2 Drivers
4.2.2.1 Increasing appearance consciousness among consumers
4.2.2.2 Growing prevalence of skin problems leading to scar formation
4.2.2.3 Increasing expenditure on personal care
4.2.2.4 Technological advancements in scar treatment products
4.2.2.5 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Side effects associated with scar treatment products
4.2.3.2 High cost of scar treatment products
4.2.3.3 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Growing demand for organic scar treatment products
4.3 Porter’s Five Forces Analysis
4.3.1 Bargaining Power of Buyers
4.3.2 Bargaining Power of Suppliers
4.3.3 Intensity of Rivalry
4.3.4 Threat of New Entrants
4.3.5 Threat of Substitutes
Chapter 5. U.S. Market Size and Forecast
5.1 By Type of Treatment
5.1.1 Topical Scar Treatment Market by Type
5.1.2 Surface Scar Treatment Market by Type
5.1.3 Laser Scar Treatment Market by Type
5.1.4 Injectable Scar Treatment Market by Type
5.2 By Type of Scar
5.3 By End User
Chapter 6. Competitive Landscape
6.1 Product Benchmarking of Key Players
6.2 Global Strategic Developments of Key Players
6.2.1 Product Launches/ Approvals
6.2.2 Other Developments
Chapter 7. Company Profiles
7.1 Revitol Corporation Inc.
7.1.1 Business Overview
7.1.2 Product and Service Offerings
7.2 Sonoma Pharmaceuticals Inc.
7.2.1 Business Overview
7.2.2 Product and Service Offerings
7.2.3 Key Financial Summary
7.3 CCA Industries Inc.
7.3.1 Business Overview
7.3.2 Product and Service Offerings
7.3.3 Key Financial Summary
7.4 Scarguard Labs LLC
7.4.1 Business Overview
7.4.2 Product and Service Offerings
7.5 Quantum Health
7.5.1 Business Overview
7.5.2 Product and Service Offerings
7.6 Valeant Pharmaceuticals International Inc.
7.6.1 Business Overview
7.6.2 Product and Service Offerings
7.6.3 Key Financial Summary
7.7 Pacific World Corporation
7.7.1 Business Overview
7.7.2 Product and Service Offerings
7.8 Merz Pharma GmbH & Co. KGaA
7.8.1 Business Overview
7.8.2 Product and Service Offerings
7.8.3 Key Financial Summary
7.9 Johnson & Johnson
7.9.1 Business Overview
7.9.2 Product and Service Offerings
7.9.3 Key Financial Summary
Chapter 8. Appendix
8.1 Abbreviations
8.2 Sources and References
8.3 Related Report
LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 U.S. SCAR TREATMENT MARKET, BY TYPE OF TREATMENT, $M (2013 – 2017)
TABLE 5 U.S. SCAR TREATMENT MARKET, BY TYPE OF TREATMENT, $M (2018 – 2023)
TABLE 6 U.S. TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2013 – 2017)
TABLE 7 U.S. TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2018 – 2023)
TABLE 8 U.S. SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2013 – 2017)
TABLE 9 U.S. SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2018 – 2023)
TABLE 10 U.S. LASER SCAR TREATMENT MARKET, BY TYPE, $M (2013 – 2017)
TABLE 11 U.S. LASER SCAR TREATMENT MARKET, BY TYPE, $M (2018 – 2023)
TABLE 12 U.S. INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2013 – 2017)
TABLE 13 U.S. INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2018 – 2023)
TABLE 14 U.S. SCAR TREATMENT MARKET, BY TYPE OF SCAR, $M (2013 – 2017)
TABLE 15 U.S. SCAR TREATMENT MARKET, BY TYPE OF SCAR, $M (2018 – 2023)
TABLE 16 U.S. SCAR TREATMENT MARKET, BY END USER, $M (2013 – 2017)
TABLE 17 U.S. SCAR TREATMENT MARKET, BY END USER, $M (2018 – 2023)
TABLE 18 PRODUCT BENCHMARKING OF KEY PLAYERS
TABLE 19 REVITOL CORPORATION INC– AT A GLANCE
TABLE 20 SONOMA PHARMACEUTICALS INC.– AT A GLANCE
TABLE 21 SONOMA PHARMACEUTICALS, INC. – KEY FINANCIAL SUMMARY
TABLE 22 CCA INDUSTRIESINC. – AT A GLANCE
TABLE 23 CCA INDUSTRIES INC – KEY FINANCIAL SUMMARY
TABLE 24 SCARGUARD LABS LLC – AT A GLANCE
TABLE 25 QUANTUM HEALTH – AT A GLANCE
TABLE 26 VALEANT PHARMACEUTICALS INTERNATIONAL INC – AT A GLANCE
TABLE 27 VALEANT PHARMACEUTICAL INTERNATIONAL INC – KEY FINANCIAL SUMMARY
TABLE 28 PACIFIC WORLD CORPORATION – AT A GLANCE
TABLE 29 MERZ PHARMA GMBH & CO. KGAA – AT A GLANCE
TABLE 30 MERZ PHARMA GMBH & CO. KGAA – KEY FINANCIAL SUMMARY
TABLE 31 JOHNSON & JOHNSON - AT A GLANCE
TABLE 32 JOHNSON & JOHNSON - KEY FINANCIAL SUMMARY
LIST OF FIGURES
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 SPLIT OF PRIMARY AND SECONDARY RESEARCH
FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
FIG 6 DATA TRIANGULATION APPROACH
FIG 7 U.S. SCAR TREATMENT MARKET SUMMARY
FIG 8 PORTER’S FIVE FORCES ANALYSIS
FIG 9 SNAPSHOT OF THE U.S. SCAR TREATMENT MARKET BY TYPE OF TREATMENT
FIG 10 U.S. SCAR TREATMENT MARKET, BY TYPE OF TREATMENT, $M (2013 – 2023)
FIG 11 U.S. TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2013 – 2023)
FIG 12 U.S. SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2013 – 2023)
FIG 13 U.S. LASER SCAR TREATMENT MARKET, BY TYPE, $M (2013 – 2023)
FIG 14 U.S. INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2013 – 2023)
FIG 15 U.S. SCAR TREATMENT MARKET, BY TYPE OF SCAR, $M (2013 – 2023)
FIG 16 U.S. SCAR TREATMENT MARKET, BY END USER, $M (2013 – 2023)
FIG 17 SONOMA PHARMACEUTICALS, INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 18 CCA INDUSTRIES INC – REVENUE SPLIT BY SEGMENT (2023)
FIG 19 VALEANT PHARMACEUTICAL INTERNATIONAL INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 20 MERZ PHARMA GMBH & CO. KGAA – REVENUE SPLIT BY GEOGRAPHY (2023)
FIG 21 JOHNSON & JOHNSON - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
